BioMarin Pharmaceutical has struck a deal to purchase fellow biotechnology firm Amicus Therapeutics for about $4.8 billion in money.
Source link
BioMarin to Buy Rare-Disease Biotech Amicus Therapeutics for $4.8 Billion
Related Posts
Memory crisis hits such extremes that ‘even Apple can’t be safe’
Apple CEO Tim Prepare dinner and Jalen Brunson, basketball participant for the New York Knicks, through the first day of…
Amazon to Invest $50 Billion Building Data Centers to Support U.S. Government
Amazon.com stated it’s going to make investments $50 billion to broaden synthetic intelligence and high-performance computing capabilities for its cloud…
Tech, Media & Telecom Roundup: Market Talk
Discover perception on Nvidia, Salesforce, CrowdStrike and extra within the newest Market Talks overlaying Expertise, Media and Telecom. Source link